LH — Labcorp Holdings Inc. stock price and chart

Labcorp Holdings Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.04% · Russell 1000 0.03% · US Stock Market 0.03% · Russell 3000 0.03% · MSCI World 0.02% · MSCI ACWI 0.02%

$320.71-0.63%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDD

20162019202120242026

100.0150.0200.0250.0300.005.0M10.0M$320.71

2026-09-18

Price$320.71

MA20$286.35

MA50$275.23

Vol4.4M

What would $1,000 invested in LH be worth today? →

LH returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $320.71
Change YTD: +27.83%
Next earnings: Oct 27, 2026
Market cap: 26B2016-09 12.2B2026-09 26B+113.8% over the window
Enterprise value: 33.6B
Shares outstanding: 81.1M2016-06 102.3M2026-06 81.1M-20.7% over the window
52W low: $244.52
52W high: $341.80
From 52W high: -6.17%
From 52W low: +31.16%
52W range: 78%
Beta: 0.87

Volume

Rel volume: 2.56×
30D volume: 671.5K
30D $ vol: 218.3M

Fundamentals

Sales (ttm): 14.3B2016-06 16.7B2026-06 14.3B-14.0% over the window
Sales/share: $176.922016-06 $163.152026-06 $176.92+8.4% over the window
EPS (ttm): $12.082016-06 $6.122026-06 $12.08+97.4% over the window
FCF (ttm): 1.2B2016-06 858.4M2026-06 1.2B+34.6% over the window
FCF/share: $14.242016-06 $8.392026-06 $14.24+69.8% over the window
Book value/share: $106.132016-06 $51.942026-06 $106.13+104.3% over the window
Net margin: 6.99%2016-06 3.8%2026-06 7.0%+84.2% over the window
ROE: 11.65%2016-06 11.9%2026-06 11.6%-2.2% over the window
ROA: 5.41%2016-06 4.5%2026-06 5.4%+21.3% over the window
Debt / equity: 0.68×2016-06 1.122026-06 0.68-39.4% over the window
Current ratio: 1.802016-06 2.082026-06 1.80-13.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.41%2025-06-30 → 2026-06-3013.5B → 14.3B (+6.4% total)+5.59%2022-12-31 → 2026-06-3011.9B → 14.3B (+20.9% total)-2.62%2021-06-30 → 2026-06-3016.4B → 14.3B (-12.4% total)-1.50%2016-06-30 → 2026-06-3016.7B → 14.3B (-14.0% total)
Net income: +31.32%2025-06-30 → 2026-06-30763.4M → 1B (+31.3% total)-6.74%2022-12-31 → 2026-06-301.3B → 1B (-21.6% total)-19.03%2021-06-30 → 2026-06-302.9B → 1B (-65.2% total)+4.71%2016-06-30 → 2026-06-30632.9M → 1B (+58.4% total)
FCF: -8.45%2025-06-30 → 2026-06-301.3B → 1.2B (-8.4% total)-14.01%2023-09-30 → 2026-06-301.7B → 1.2B (-34.0% total)-16.45%2021-06-30 → 2026-06-302.8B → 1.2B (-59.3% total)+3.01%2016-06-30 → 2026-06-30858.4M → 1.2B (+34.6% total)
Shares: -2.41%2025-06-30 → 2026-06-3083.1M → 81.1M (-2.4% total)-2.68%2023-03-31 → 2026-06-3088.6M → 81.1M (-8.5% total)-3.40%2021-06-30 → 2026-06-3096.4M → 81.1M (-15.9% total)-2.30%2016-06-30 → 2026-06-30102.3M → 81.1M (-20.7% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +33.26%2025-06-30 → 2026-06-30$9.07 → $12.08 (+33.2% total)-4.07%2022-12-31 → 2026-06-30$13.97 → $12.08 (-13.5% total)-16.23%2021-06-30 → 2026-06-30$29.29 → $12.08 (-58.7% total)+7.04%2016-06-30 → 2026-06-30$6.12 → $12.08 (+97.4% total)
Sales/share: +9.04%2025-06-30 → 2026-06-30$162.26 → $176.92 (+9.0% total)+8.26%2022-12-31 → 2026-06-30$134.06 → $176.92 (+32.0% total)+0.80%2021-06-30 → 2026-06-30$170.00 → $176.92 (+4.1% total)+0.81%2016-06-30 → 2026-06-30$163.15 → $176.92 (+8.4% total)
FCF/share: -6.19%2025-06-30 → 2026-06-30$15.18 → $14.24 (-6.2% total)-12.57%2023-09-30 → 2026-06-30$20.61 → $14.24 (-30.9% total)-13.51%2021-06-30 → 2026-06-30$29.42 → $14.24 (-51.6% total)+5.44%2016-06-30 → 2026-06-30$8.39 → $14.24 (+69.8% total)
Book value/share: +4.09%2025-06-30 → 2026-06-30$101.96 → $106.13 (+4.1% total)-2.89%2023-03-31 → 2026-06-30$116.72 → $106.13 (-9.1% total)-0.18%2021-06-30 → 2026-06-30$107.07 → $106.13 (-0.9% total)+7.41%2016-06-30 → 2026-06-30$51.94 → $106.13 (+104.3% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$2.88 → $2.88 (+0.0% total)-15.47%2023-09-30 → 2026-06-30$4.57 → $2.88 (-37.0% total)n/an/a
Price: +15.73%2025-09-18 → 2026-09-18$277.15 → $320.71 (+15.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+16.82%2023-09-18 → 2026-09-18$201.17 → $320.71 (+59.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.75%2021-09-17 → 2026-09-18$254.24 → $320.71 (+26.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.67%2016-09-16 → 2026-09-18$116.31 → $320.71 (+175.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +16.90%2025-09-18 → 2026-09-18$274.37 → $320.71 (+16.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.18%2023-09-18 → 2026-09-18$194.26 → $320.71 (+65.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.87%2021-09-17 → 2026-09-18$241.08 → $320.71 (+33.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.26%2016-09-16 → 2026-09-18$110.29 → $320.71 (+190.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 26.5×2016-09 18.502026-09 25.95+40.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.4×2016-09 9.932026-09 17.38+75.1% over the window
Fwd P/E: 16.2×
P/S (ttm)Market cap ÷ TTM revenue.: 1.8×2016-09 0.722026-09 1.81+150.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.0×2016-09 2.172026-09 3.02+39.2% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 22.5×2016-09 14.802026-09 22.52+52.1% over the window
EV/EBITDA (fy): 15.3×
EV/Sales (ttm): 2.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.44%2016-06 7.1%2026-06 5.1%-28.0% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.90%
Dividend/share (fwd): $2.88
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 81.1M ÷ 83.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 2.41%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (2.41%) + dividends paid over that year ($239.1M) ÷ market_cap_at(2025-06-30) ($21.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.50%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($701.8M) ÷ today's market cap ($26B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.70%2016-06 0.0%2026-06 3.1%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $701.8M + TTM dividends $239.1M) ÷ today's market cap ($26B). Same caveat as the cash buyback yield.: 3.62%2016-06 0.0%2026-06 4.1%

Vs own 10Y history

P/E: 77th
P/OI: 79th
P/S: 99th
P/B: 99th
P/FCF: 92nd

Bar = where today’s multiple sits in LH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-0.63%

+2.94%

-0.46%

+25.37%

YTD

+27.83%

+15.72%

+26.15%

Financial statements

Open full LH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Labcorp Holdings Inc. (LH) trades at $320.71 with a live price and an interactive chart covering 36+ years of daily price history, plus key valuation metrics. ChartRow also publishes LH’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full LH financial statements →

LH — Labcorp Holdings Inc. price, chart and key statistics